# OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

> clinical trial · VERIFIED · 2026-08-17

Status: TERMINATED · Sponsor: ACADIA Pharmaceuticals Inc. · Condition: Hyperphagia in Prader-Willi Syndrome

- Company: ACADIA Pharmaceuticals Inc.
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT06420297

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.